UK markets open in 1 hour 12 minutes

Bionano Genomics, Inc. (BNGO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.8048+0.0296 (+3.82%)
At close: 04:00PM EDT
0.8209 +0.02 (+2.00%)
After hours: 06:57PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 56.63M
Enterprise value 41.73M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.87
Price/book (mrq)0.68
Enterprise value/revenue 1.11
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.34
52-week change 3-87.10%
S&P500 52-week change 325.87%
52-week high 36.8000
52-week low 30.7100
50-day moving average 30.9274
200-day moving average 31.4993

Share statistics

Avg vol (3-month) 31.26M
Avg vol (10-day) 3911.11k
Shares outstanding 569.11M
Implied shares outstanding 669.11M
Float 858.6M
% held by insiders 10.48%
% held by institutions 120.03%
Shares short (15 May 2024) 44.98M
Short ratio (15 May 2024) 44.01
Short % of float (15 May 2024) 48.54%
Short % of shares outstanding (15 May 2024) 47.45%
Shares short (prior month 15 Apr 2024) 45.36M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 307 Aug 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 0.00%
Operating margin (ttm)-304.29%

Management effectiveness

Return on assets (ttm)-35.84%
Return on equity (ttm)-144.33%

Income statement

Revenue (ttm)37.47M
Revenue per share (ttm)0.94
Quarterly revenue growth (yoy)18.30%
Gross profit (ttm)N/A
EBITDA -115.53M
Net income avi to common (ttm)-226.79M
Diluted EPS (ttm)-6.1800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)28.32M
Total cash per share (mrq)0.42
Total debt (mrq)37.87M
Total debt/equity (mrq)45.75%
Current ratio (mrq)1.46
Book value per share (mrq)1.44

Cash flow statement

Operating cash flow (ttm)-120.9M
Levered free cash flow (ttm)-76.4M